News tagged with gsk
Elan enters $1B royalty deal with Theravance
Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. and GlaxoSmithKline.
Medications
May 13, 2013 |
not rated yet |
0
Save the Children teams up with pharma giant GSK in Africa
International development charity Save the Children is linking up with British pharmaceutical giant GlaxoSmithKline in what both sides say is a unique collaboration to save children's lives in Africa.
Medications
May 10, 2013 |
not rated yet |
0
Drugmaker GSK posts slumping Q1 profits
British drugs firm GlaxoSmithKline on Wednesday said its first-quarter net profit tumbled by almost a third, with the group hit by falling sales and a poor economic climate.
Medications
Apr 24, 2013 |
not rated yet |
0
UK alleges GSK paid off competitors to delay drugs
Britain's competition watchdog accused GlaxoSmithKline on Friday of paying off competitors to delay launches of their own versions of GSK's best-selling antidepressant, Seroxat.
Medications
Apr 19, 2013 |
not rated yet |
1
Drugmaker GSK reveals lower profits, restructuring
British drugs firm GlaxoSmithKline on Wednesday unveiled a 13-percent drop in annual net profits and outlined a plan for more restructuring in Europe to deliver greater savings and offset weaker sales across the region.
Other
Feb 06, 2013 |
not rated yet |
0
Major step toward an Alzheimer's vaccine
A team of researchers from Université Laval, CHU de Québec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain's natural defense mechanisms in people with Alzheimer's disease. This ...
Alzheimer's disease & dementia
Jan 15, 2013 |
5 / 5 (4) |
0
Study identifies key cellular mechanisms behind the onset of tinnitus
Researchers in the University of Leicester's Department of Cell Physiology and Pharmacology have identified a cellular mechanism that could underlie the development of tinnitus following exposure to loud noises. The discovery ...
Diseases, Conditions, Syndromes
May 10, 2012 |
2 / 5 (1) |
0
|
GSK launches hostile $2.6 bn bid for Human Genome Sciences
British drugmaker GlaxoSmithKline on Wednesday said it had gone hostile over its $2.6 billion (2.0 billion-euro) takeover bid for US research partner Human Genome Sciences Inc.
Medications
May 09, 2012 |
not rated yet |
0
Glaxo sells key European brands to Belgium's Omega Pharma
British drugmaker GlaxoSmithKline said Thursday that it would sell a stable of well-known European over-the-counter brands, including Nytol sleep aid, to Belgium's Omega Pharma.
Other
Mar 15, 2012 |
not rated yet |
0
British drugs firm GSK settles US drug disputes for $3.0 bln
GlaxoSmithKline said on Thursday it had agreed to pay $3.0 billion (2.2 billion euros) to settle long-running disputes with the US government over how the British pharmaceuticals group marketed and developed drugs.
Medications
Nov 03, 2011 |
5 / 5 (1) |
0
Drug firm GSK fined $2.6 million for collusion
South Korea's anti-trust agency has fined drugmaker GlaxoSmithKline three billion won ($2.6 million) for conspiring with a Seoul rival over the sale of drugs, an official said Monday.
Medications
Oct 24, 2011 |
not rated yet |
0
GSK
GSK could refer to:
For more information about GSK, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
